Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Mexico issues regulations to approve biologic drugs
        2. Latin America Roundtable
        3. New regulations pending
        4. The International Comparative Guide
        5. Marketing authorization for pharmaceutical
        6. Approval of follow-on biologics in Mexico
        7. Mexican Linkage Gazette April 2011
        8. Patent Prosecution Highway in Mexico
        9. Life Sciences Handbook 2011 - Country Q&A
        10. Data Package Exclusivity (DPE)
        11. 35 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Amendments to the Federal Law for Consumer Protection
        2. Mexico issues Personal Data Protection Rules
        3. New Regulations Pending
        4. Marketing authorization for pharmaceutical products to foreign applicants
        5. Data Package Exclusivity (DPE)
        6. Supreme Court upholds the worth of formulation patents
        7. Pharmaceutical trademarks
        8. Framework for biotherapeutic products established
        9. Pharmaceutical Advertising 2009
        10. New Regulations for pharma industry
        11. 3 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Whither Rental Rights?
        2. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Presumed Guilty - How can a law firm help win an Emmy?
      2. New rules came in force to speed timeframes in administrative appeal proceedings
      3. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      4. Olivares & Cia. ranking
      5. Data Package Exclusivity (DPE)
      6. Mr. Sergio Olivares Sr's Passing
      7. Pharma Linkage Regulations Supreme Court Decision
      8. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      9. Mexican Congress amends the Patent Law
      10. Implementation of the Federal Law for the Protection of Personal Data in Possession of Private Entities
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Copyright Law Articles » Protecting novel ideas

Protecting novel ideas

By Maria Dolores Kralj, Managing Intellectual Property, International Briefings, June 2009.
One of the cornerstones of the copyright system is the idea/expression dichotomy, which sets forth that only the original expression of ideas is to be protected, rather than the ideas themselves. This principle poses important challenges for the creative industries, since the distinction between an idea and the expression of that idea is sometimes unclear.
For example, once an entertainment company has come up with a good idea, it then needs to sell it. To do so, it has to communicate the idea to others – either orally or in writing – and therein lies the legal challenge. If ideas (as opposed to their expression) are not protected by copyright law, how can these creative companies make sure that people having access to their ideas will not use them without their authorisation? What kind of protection can they find in a situation like this? Is copyright law an efficient mechanism?
The judiciary has been answering these questions in varying ways, which implies that we cannot count on copyright law protection as an effective tool for avoiding the potential unauthorised use of ideas. Instead, entertainment companies selling ideas for TV formats can supersede the grey area posed by the idea/expression dichotomy by making sure that, before releasing their original ideas, they execute with the company or person gaining access to those ideas a confidentiality agreement, by which the other party expressly agrees not to use those ideas without the creator's authorisation.
Moreover, the confidentiality agreement should have, among other relevant characteristics – such as adequate information management provisions and an efficient dispute resolution clause – a penalty clause to persuade the other party not to breach the confidentiality agreement and, in case of dispute, to avoid a long trial to determine damages.
Lastly, it is highly important to bear in mind that each individual case may have particular nuances. As legal advice must be tailored to the specific circumstances of each case, competent legal counsel should be consulted.